The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015. Australia hasn’t followed suit, though flib
The fantasy makes sense: “Sex is hotter when it’s a little transgressive,” says Stephen Snyder, M.D., a sex and relationship therapist in New York City. “There’s something about the surprise of taking off the wrapper for the first time.”